La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Bolt Biotherapeutics a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Bolt Biotherapeutics..

Bolt Biotherapeutics (NASDAQ:BOLT) Azioni, Catena delle Opzioni

Bolt Biotherapeutics

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

Bolt Biotherapeutics, Inc. - Common Stock

Bolt Biotherapeutics Inc

BOLT

Bolt Projects Holdings, Inc. - Common Stock

Bolt Projects Holdings Inc

Bolt Metals Corp

Health Care

Press Releases

Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.

News

Bolt Biotherapeutics to Participate in Upcoming March Conferences

Earnings

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

Bio Green Med Solution, Inc. - Common Stock

Bio Green Med Solution

BioRestorative Therapies, Inc. - Common Stock

BioRestorative Therapies

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma

Carisma Therapeutics, Inc. - Common Stock

CARISMA Therapeutics

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

ESSA Pharma

Ernexa Therapeutics

Evogene

Genprex

Imunon

IN8bio

Intensity Therapeutics, Inc. - Common Stock

Intensity Therapeutics

Kala Bio

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Mustang Bio

Marker Therapeutics

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

OSR Holdings

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharma

TransCode Therapeutics, Inc. - Common Stock

TransCode Therapeutics

SILO Pharma

Silexion Therapeutics Corp - Ordinary Shares

Silexion Therapeutics

Soligenix

XTL Biopharmaceuticals Ltd. - American Depositary Shares

XTL Biopharmaceuticals

Lake Street

Stifel

Leerink Partners

SVB Leerink

Morgan Stanley

Bolt Technology

Screenshot 2024-12-06 at 6.41.42 PM

Emerging Markets

Commodities

Movers & Shakers

Markets

PACIFIC RIM COBALT CORP by Pacific Rim Cobalt Corp.

Comments

Bolt Biotherapeutics

Bolt Biotherapeutics (BOLT) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO